RSNA 2024
RSNA 2024 – Radiological Society of North America Annual Meeting
Booth 4747 | Chicago, IL | December 1-5, 2024
It’s About Time.
To elevate breast health with precision and clarity.
Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.
Learn how iCAD’s AI solutions can elevate your breast health approach.
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
Cancer wins when it hides.
When it comes to cancer, hide and seek is no game.
iCAD is creating a world where cancer can’t hide with innovative artificial intelligence solutions that empower providers and professionals to accurately, reliably and quickly detect cancer and improve outcomes – optimizing every patient’s opportunity to live better, longer lives.
iCAD Happy Hour Appreciation Event
AI in the Sky: Discover ProFound Insights & Breast Health Innovations.
Join iCAD for an RSNA 2024 Appreciation Event at the VU Rooftop, Sunday, December 1st at 6:00 PM.
ProFound on Stage: 2024 Event Program
Scientific Presentation (Oral)
AI Theater Presentation
Breast AI Panel Discussions
GE HealthCare
GE HealthCare Expert Corner
- GE HealthCare (Digital Solutions) Booth 7330 (North Hall)
- Daily at 10:00 AM-2:00 PM
Densitas
Elevating Patient Care through Quality Images & Precise Detection
- Densitas Booth #2806 | iCAD Booth #4747
- Monday, December 2 at 10:00 AM | Tuesday, December 3 at 10:00 AM
Blackford Analysis
Blackford Panel: Enhancing Breast Cancer Care with AI.
- Blackford Booth 4729 (South Hall)
- Tuesday, December 3, 2:30-2:50 PM
CARPL.ai
CARPL.ai Breast AI Panel
- CARPL.ai Booth 5733 (South Hall)
- Wednesday, December 4, 11:00 AM
iCAD’s ProFound Detection Version 4.0
Gains FDA Clearance
Discover the Improved Readability in ProFound AI Detection V3 Service Pack.
Radiologists Asked. We Delivered.
New features help breast imaging professionals quickly identify suspicious lesions by limiting the number of marks on each 3D view, and understand the level of suspicion related to lesions and the case through color-coded scoring ranges.
Improved Readability on Workstation:
• Limited number of marks
• Color-coded lesion marks
• Color-coded scorecard
Introducing iCAD’s AI Platform
ProFound Breast Health Suite
Powered by the latest innovations in artificial intelligence (AI), the ProFound Suite offers clinically proven, 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation. With about 2x improvement in clinical performance compared to other AI platforms,1 ProFound offers unrivaled accuracy, as well as multi‐vendor compatibility and unique workflow advantages.
Joining forces against a common enemy.
In the fight against cancer, we’re stronger together. Learn why our customers believe that our solutions are the secret weapon for cancer detection and treatment.
“ProFound AI has provided a great deal of assistance in mammography decisions. ProFound AI uses artificial intelligence to rapidly and accurately analyze patients’ digital breast tomosynthesis images, producing a unique and quantifiable Certainty of Finding score for the patients’ overall case”.
KATHY SCHILLING, MD
Radiologist, Boca Raton Regional Hospital
“ProFound AI is a game-changer, helping us more confidently and efficiently move through cases, and with more accuracy than ever before. Whether recommending a biopsy or confidently dismissing a case, ProFound AI empowers our team with crucial insights that aid in clinical decisions”.
LAURA H. DEAN, MD
Radiologist, Section of Breast Imaging, Cleveland Clinic
“Our retrospective study shows that AI has the potential to correctly identify a third of DBT screening exams as having no malignancy or an extremely low likelihood of malignancy. This AI-triaging could help radiologists determine which cases may need more intensive analysis”.
Emily F. Conant
Professor of Radiology and Vice Chair of Faculty Development in the Department of Radiology at the University of Pennsylvania, Perelman School of Medicine
Patient-Driven, AI-Powered
Creating a World Where Cancer Can’t Hide.
Implementation made easy.
Streamlining mammography workflows to create efficiencies and peace of mind.
With thousands of installations worldwide, our solutions offer multi-vendor compatibility that seamlessly integrate into the diagnostic process, in any reading environment.
Flexible turnkey solutions and service options designed to meet your unique deployment needs
ProFound Cloud
Connect via your private cloud, AI-marketplace, or directly with iCAD’s native cloud and support plans.
ProFound On-Premises
Onsite hardware conveniently pre-loaded with iCAD software plus warranty and service plans.
Interoperability: 50+ PACS & 94 versions | 2D & 3D OEM manufacturers | AI platform providers & workflow systems
Let’s Connect at RSNA
We look forward to meeting with you.
Schedule a time to connect with us live or virtually to discuss how iCAD’s ProFound AI Breast Health Suite of solutions can best support your current workflow needs.
ProFound AI is FDA Cleared. CE Marked. Health Canada Licensed. ProFound Risk is CE marked (MDD) and Health Canada Licensed. May not be available in all geographies. Heart Health may not be available in all geographies.
1. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm. Accessed 1-20-23. FDA 510K submissions K182373 (iCAD), K201019 (Hologic) and K193229 (ScreenPoint).
2. https://www.nationalbreastcancer.org/early-detection-of-breast-cancer. Accessed 11-01-2023